Advertisement

Topics

Search Results for "Rna Interference Patents Dr Allen"

01:13 EDT 29th September 2016 | BioPortfolio

Matching Channels

Biosuperior Antibodies

After biosimilar versions of therapeutic proteins have become reality in Europe and in the US, now it’s the turn of therapeutic antibodies to be in the line of fire. Patents of the first wave of...

Tumor Necrosis Factor TNF Products

Tumor Necrosis Factor (TNF) and TNF receptor antagonists and agonists used to treat TNF-mediated inflammatory diseases such as rheumatoid arthritis or to treat cancer. TNF blockers are the commerc...

Coagulation Factors

Fourteen different blood coagulation factors are present in the body. Each plays a crucial role in the process described above. Some work to increase the activity level of the other factors while so...

Matching News

Paul G. Allen announces $100 million to launch the Paul G. Allen Frontiers Group

(Allen Institute) Philanthropist and entrepreneur Paul G. Allen today announced an initial commitment of $100 million to create The Paul G. Allen Frontiers Group, whose purpose will be to explore the ...

Paul Allen Announces Funding for Research at the Frontiers of Bioengineering and Systems Biology

Bio-IT World | Paul Allen, the co-founder of Microsoft and a lavish philanthropist in the life sciences, has made a $100 million commitment to a new scientific grant program, the Paul G. Allen Fr...

Paul G. Allen Frontiers Group to launch for ‘out-of-the-box’ research

Philanthropist and entrepreneur Paul G. Allen has announced an initial commitment of $100 million to create The Paul G. Allen Frontiers Group, whose purpose will be to explore the landscape of bios...

#news #biotech Microsoft co-founder Paul Allen launches $100M bioscience fund

// The Paul G. Allen Frontiers Group has officially launched today as the life sciences funding arm of the Allen Institute. The Group, headquartered in Seattle, WA, has been set up by the multi-millio...

What Paul Allen, Orson Welles And A Mouse Are Teaching Us About Our Brains

Microsoft co-founder Paul Allen has launched a new initiative designed to aid researchers who study brain function.

Lonza Overcoming Interference e-Learning Module

Lonza has announced the release of the Overcoming Interference e-Learning Module for its QC Insider Toolbox, which covers the causes of interference in the bacterial endotoxins test (BET) and provides...

Paul Allen's Plan To Pour $100M Into 'Out-Of-The-Box' Biotech Research

The new Paul G. Allen Frontiers Group, backed by $100 million from the Microsoft co-founder, will provide vital funding to scientists with out-there ideas for solving medical problems.

Controlling Gene Expression with CRISPR Interference (CRISPRi)

The genome editing technology, CRISPR/Cas9, is well known for assisting researchers in manipulating the genome of target cells and has already been discussed in a few posts. This article is about repu...

Matching PubMed Articles

Extending the market exclusivity of therapeutic antibodies through dosage patents.

Dosage patents are one way to extend the market exclusivity of an approved drug beyond the lifetime of the patent that protects the drug as such. Dosage patents may help to compensate the applicant fo...

Searching bioremediation patents through Cooperative Patent Classification (CPC).

Patent classification systems have traditionally evolved independently at each patent jurisdiction to classify patents handled by their examiners to be able to search previous patents while dealing wi...

Patent litigation in India continues to throw up new challenges.

For several years after the reinstitution of a pharmaceutical patent regime in India, most innovator pharmaceutical companies have faced a string of high-profile defeats during litigation in India. In...

Big Data from Pharmaceutical Patents: A Computational Analysis of Medicinal Chemists' Bread and Butter.

Multiple recent studies have focused on unraveling the content of the medicinal chemist's toolbox. Here, we present an investigation of chemical reactions and molecules retrieved from US patents over ...

Divided Infringement in the Limelight of the Patent Battle Field.

Diagnostic patents usually comprise multiple steps and can be jointly implemented by different parties. However, in the USA, joint implementation may render diagnostic patents unenforceable in light o...

Search Whole site using Google

Loading
Quick Search
Advertisement
 
Advertisement Advertisement